Real world data show that immunotherapy leads to better overall survival outcomes than chemotherapy in patients with ...

An emotional rescue for America came via the first U.S. artificial satellite. Explorer 1 was boosted into space by the Army ...

The GI Cancers Symposium revealed new therapies for specific cancer subsets and progress in chimeric antigen receptor T-cell ...

SpinLaunch, a company looking to throw satellites into orbit, has secured investment and signed a contract to deploy its own ...

Black patients with metastatic triple-negative breast cancer received immunotherapy less frequently than patients of other ...

Other rapidly expanding Finnish start-ups in the defence and dual-use sectors include Iceye, which has developed ...

Researchers have revived prehistoric algae from Baltic Sea sediment nearly 7,000 years old, offering clues about how life ...

Finland’s decision to withdraw from the Ottawa Treaty signals a decisive shift in European security policy as growing ...

Colorectal cancer is a serious but preventable disease if detected early. Advances in diagnostics, such as biomarker analysis ...

On March 5, 2025, the FDA cleared an investigational new drug application for CTD402, a CD7-targeted universal CAR T-cell ...

IDEAYA Biosciences, Inc.’s IDYA share price has surged by 10.70%, which has investors questioning if this is right time to sell.